
Aptose Biosciences rose 0.4% from $1.68 to $1.69, behind the S&P 500's +10.2%. Its worst day was May 28 (−6.5%), and its low came Dec 24 at $1.45.
Nov 19, 2025 – Jul 2, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Aptose Biosciences closed at its lowest level of the year, 13.8% below where the year started.
−4.0% · S&P 500 +0.4%
Aptose Biosciences shares fell 6.4%, while the S&P 500 fell 0.6%.
−6.4% · S&P 500 −0.6%
Story events cover the past 12 months · Times ET
Aptose Biosciences closed at its highest level of the year, 2.8% above where the year started.
+3.0% · S&P 500 +0.2%
Aptose Biosciences shares fell 6.5%, while the S&P 500 rose 0.6%.
−6.5%, the year's worst day · S&P 500 +0.6%
Where it ended: a close of $1.69 on Jul 2, 2026.
Nothing in the past 12 months.
All APTOF earningsNothing in the past 12 months.
All APTOF analyst actionsNothing in the past 12 months.
All APTOF dividend history